Related Experiment Videos
Nitric oxide dysfunction in the pathophysiology of preeclampsia
1375th Medical Group, Scott Air Force Base, Illinois 62225, USA. duane.lowe@scott.af.mil
Nitric Oxide : Biology and Chemistry
|August 17, 2000
Summary
Preeclampsia may stem from low nitric oxide (NO) and high peroxynitrite (ONOO(-)) levels, causing key physiological changes. This imbalance offers new avenues for preeclampsia prevention and treatment.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Physiology
- Renal Physiology
Background:
- Nitric oxide (NO) plays a crucial role in vascular homeostasis.
- The exact role of NO dysfunction in preeclampsia remains debated.
- Few studies have linked NO dysregulation to metabolic disturbances in preeclampsia.
Purpose of the Study:
- To review evidence implicating NO deficiency and peroxynitrite excess in preeclampsia pathogenesis.
- To correlate these NO-related dysfunctions with known preeclampsia pathophysiology.
- To propose novel therapeutic and preventive strategies based on NO-related mechanisms.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of physiological and serological data in preeclampsia.
- Correlation of NO/ONOO(-) balance with clinical manifestations.
Main Results:
- Evidence suggests a primary dysfunction involves reduced NO availability and increased peroxynitrite.
- This imbalance can initiate major preeclampsia changes: elevated blood pressure, glomerular filtration rate, proteinuria, platelet dysfunction, and altered prostacyclin levels.
- Increased thromboxane and endothelin are also linked to this NO/ONOO(-) imbalance.
Conclusions:
- A relative deficiency of NO and excess of peroxynitrite may be the central defect in preeclampsia.
- This understanding could explain the failure of past treatments.
- Targeting NO bioavailability and reducing oxidative stress may offer future therapeutic and preventive strategies.